PISCUOGLIO, SALVATORE
 Distribuzione geografica
Continente #
AS - Asia 2.097
NA - Nord America 1.573
SA - Sud America 596
EU - Europa 347
AF - Africa 47
OC - Oceania 4
Totale 4.664
Nazione #
US - Stati Uniti d'America 1.520
SG - Singapore 1.315
BR - Brasile 501
CN - Cina 394
VN - Vietnam 132
HK - Hong Kong 109
IT - Italia 100
GB - Regno Unito 39
AR - Argentina 38
DE - Germania 35
RU - Federazione Russa 28
FI - Finlandia 25
MX - Messico 24
IN - India 23
EC - Ecuador 22
BD - Bangladesh 20
CA - Canada 19
PL - Polonia 16
TR - Turchia 15
FR - Francia 14
NL - Olanda 12
ID - Indonesia 11
IE - Irlanda 11
NG - Nigeria 11
SE - Svezia 11
ZA - Sudafrica 11
PY - Paraguay 10
UZ - Uzbekistan 10
JP - Giappone 9
MA - Marocco 9
CO - Colombia 8
ES - Italia 8
IQ - Iraq 8
VE - Venezuela 8
KG - Kirghizistan 7
SA - Arabia Saudita 7
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
AM - Armenia 4
AT - Austria 4
BE - Belgio 4
EG - Egitto 4
KE - Kenya 4
LT - Lituania 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
IL - Israele 3
LB - Libano 3
NP - Nepal 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
PH - Filippine 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 4.664
Città #
Singapore 379
The Dalles 316
Shanghai 222
Ashburn 149
New York 145
Dallas 144
Beijing 116
Hong Kong 108
Wilmington 55
Ho Chi Minh City 53
Chandler 52
São Paulo 48
Boardman 43
Los Angeles 38
Milan 36
San Mateo 32
Hanoi 31
Helsinki 24
Brooklyn 15
Seattle 15
Warsaw 15
Naples 14
Santa Clara 14
Belo Horizonte 13
Lawrence 12
Munich 12
Princeton 12
Boston 11
Dublin 11
Benin City 10
Rio de Janeiro 10
Tashkent 10
Council Bluffs 9
Fairfield 9
Johannesburg 9
Moscow 9
Paris 9
San Francisco 9
Tokyo 9
Abbiategrasso 8
Atlanta 8
Campinas 8
Dhaka 8
Goiânia 8
London 8
Manchester 8
Mexico City 8
Phoenix 8
Ankara 7
Bishkek 7
Biên Hòa 7
Brasília 7
Chennai 7
Guayaquil 7
Haiphong 7
Montreal 7
Stockholm 7
Buenos Aires 6
Orem 6
Porto Alegre 6
Quito 6
Amsterdam 5
Ann Arbor 5
Brno 5
Chicago 5
Curitiba 5
Denver 5
Fortaleza 5
Guarulhos 5
Joinville 5
Mumbai 5
Recife 5
Salvador 5
Assago 4
Brussels 4
Da Nang 4
Istanbul 4
Leawood 4
Mauá 4
Piracicaba 4
Reston 4
Ribeirão Preto 4
Sorocaba 4
Sumaré 4
Vicopisano 4
Woodbridge 4
Yerevan 4
Aracaju 3
Araçatuba 3
Baghdad 3
Bauru 3
Birmingham 3
Bogotá 3
Bắc Giang 3
Cariacica 3
Caruaru 3
Casablanca 3
Caxias do Sul 3
Cleveland 3
Colombo 3
Totale 2.542
Nome #
SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules 177
PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition 82
PS-24-008 Prevalence of vessels encapsulating tumour clusters (VETC) in human cancers 78
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 76
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. 70
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 67
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 61
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal can-cer. 54
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 51
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients 49
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study 48
Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients 47
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 46
The protein histidine phosphatase LHPP is a tumour suppressor 45
Variant Calling Methods and Protocols 43
The Genomic Landscape of Male Breast Cancers 43
Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma 42
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 42
Arginine reprograms metabolism in liver cancer via RBM39 41
Breast cancer intra-tumor heterogeneity 41
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 40
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 39
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 38
3 '-UTR Poly(T/U) Tract Deletions and Altered Expression of EWSR1 Are a Hallmark of Mismatch Repair-Deficient Cancers 38
A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth 38
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 37
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle 36
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 36
In vivo interaction screening reveals liver-derived constraints to metastasis 36
Colitis Is Associated with Loss of the Histidine Phosphatase LHPP and Upregulation of Histidine Phosphorylation in Intestinal Epithelial Cells 35
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 35
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 35
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer 35
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle (vol 25, pg 1729, 2014) 34
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 34
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 33
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors 33
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 33
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 33
Genomic landscape of adenoid cystic carcinoma of the breast 33
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis 32
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 32
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 32
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 32
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 32
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 32
Genomic characterization of metastatic breast cancers 31
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 31
Skeletal Muscle Disorders: A Non-cardiac Source of Cardiac Troponin T 31
Patient-derived xenografts and organoids model therapy response in prostate cancer 31
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 31
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 30
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 30
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity 30
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 30
mTOR signaling mediates ILC3-driven immunopathology 30
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma 30
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 29
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 29
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 29
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 29
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 29
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 28
Author Correction: Genomic characterization of metastatic breast cancers (Nature, (2019), 569, 7757, (560-564), 10.1038/s41586-019-1056-z) 28
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast 28
Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids 28
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens 28
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 28
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer 27
A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer 27
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 27
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 27
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy 27
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 27
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 27
Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies 27
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology 27
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 26
Survivin Expression in Renal Cell Carcinoma 26
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 26
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 26
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 26
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 26
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 26
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile 26
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 26
Probabilistic pathway-based multimodal factor analysis 26
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function 26
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas 25
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 25
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 25
Fragment-sequencing unveils local tissue microenvironments at single-cell resolution 24
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 24
Uterine adenosarcomas are mesenchymal neoplasms 24
Minor intron splicing is critical for survival of lethal prostate cancer 24
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples 24
Establishing standardized immune phenotyping of metastatic melanoma by digital pathology 24
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers 24
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast 24
HMGA1 expression in human hepatocellular carcinoma correlates with poor prognosis and promotes tumor growth and migration in in vitro models (vol 18, pg 724, 2016) 23
Totale 3.573
Categoria #
all - tutte 35.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.396


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 16 20 6 21 16 0 19
2021/202256 1 0 1 16 0 0 1 12 2 1 12 10
2022/2023146 26 10 26 10 11 9 1 15 19 16 3 0
2023/2024671 1 12 16 4 5 215 31 38 30 39 111 169
2024/20251.870 33 6 8 38 16 245 108 101 319 461 272 263
2025/20261.992 706 428 215 473 114 56 0 0 0 0 0 0
Totale 4.834